Abstract
Active monitoring strategies recently have received attention as possible treatment options for men with low-risk prostate cancer who have a life expectancy of more than 10 years. However, no current criteria sufficiently predict outcomes for individuals with clinically localized disease and an otherwise long life expectancy who undergo either immediate or delayed treatment, or no treatment. This article describes the available evidence regarding treatment outcomes in men with low-risk prostate cancer and presents the case for immediate active treatment.
Original language | English (US) |
---|---|
Pages (from-to) | 699-702 |
Number of pages | 4 |
Journal | JNCCN Journal of the National Comprehensive Cancer Network |
Volume | 5 |
Issue number | 7 |
DOIs | |
State | Published - Aug 2007 |
Keywords
- Active monitoring
- Immediate treatment
- Prostate cancer
ASJC Scopus subject areas
- Oncology